Free Newsletter
Enzyme discovery offers new direction in diabetes
A team of Australian scientists has found an enzyme in diabetics that prevents them from producing insulin. The researchers say that they intend to start working with drug developers to block PKCepsilon, raising the possibility of a simple, effective method for treating diabetes. Observers also noted that the advancement could create a therapy that would protect people at high risk from ever developing Type 2 diabetes. In an animal study, the team developed genetically modified mice without the enzyme, and found that they didn't develop diabetes even after gaining a significant amount of weight on a high-fat diet.
- see the release on the discovery
- read the the report from ABC
Related Articles:
New way to creating enzymes. Report
Diabetes epidemic triggers soaring drug market. Report
Diabetes therapies move into the research spotlight. Report
Comments
Post new comment
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession





SHARE
WITH: